UK markets close in 1 hour 8 minutes

VBI Vaccines Inc. (VBIV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5700-0.0126 (-2.16%)
As of 10:19AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 16.56M
Enterprise value 45.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.04
Price/book (mrq)2.20
Enterprise value/revenue 5.29
Enterprise value/EBITDA -0.55

Trading information

Stock price history

Beta (5Y monthly) 1.92
52-week change 3-79.14%
S&P500 52-week change 322.43%
52-week high 33.4700
52-week low 30.4500
50-day moving average 30.6042
200-day moving average 30.7523

Share statistics

Avg vol (3-month) 3466.22k
Avg vol (10-day) 3178.26k
Shares outstanding 528.43M
Implied shares outstanding 628.43M
Float 826.58M
% held by insiders 17.59%
% held by institutions 111.26%
Shares short (15 Apr 2024) 4709.47k
Short ratio (15 Apr 2024) 40.71
Short % of float (15 Apr 2024) 42.69%
Short % of shares outstanding (15 Apr 2024) 42.51%
Shares short (prior month 15 Mar 2024) 4302.88k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 328 Dec 2012
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 312 Apr 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,449.47%

Management effectiveness

Return on assets (ttm)-28.57%
Return on equity (ttm)-258.99%

Income statement

Revenue (ttm)8.68M
Revenue per share (ttm)0.56
Quarterly revenue growth (yoy)191.10%
Gross profit (ttm)N/A
EBITDA -53.32M
Net income avi to common (ttm)-93.84M
Diluted EPS (ttm)-6.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.68M
Total cash per share (mrq)0.83
Total debt (mrq)53.04M
Total debt/equity (mrq)704.66%
Current ratio (mrq)0.48
Book value per share (mrq)0.31

Cash flow statement

Operating cash flow (ttm)-60.88M
Levered free cash flow (ttm)-39.41M